drugset / Trial / NCT07208773
A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors
Non-randomizedSequentialOpen-labelTreatment
Summary
This study was designed to evaluate the efficacy and safety of YL201 in combination with Ivonescimab (AK112) in subjects with solid tumor.
Timeline
- Start
- 2025-10-29
- Primary completion
- 2027-01
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivonescimab | Monoclonal antibody | — | Intravenous |
| Subject | YL201 | Other / unclassified | — | Intravenous |